Suppr超能文献

催乳素降低率在轻度高催乳素血症诊断中的诊断效用

Diagnostic Utility of the Prolactin Decrease Rate in the Diagnosis of Mild Hyperprolactinemia.

作者信息

Güneş Mutlu, Güneş Elif, Çetinkaya Altuntaş Seher

机构信息

Department of Endocrinology, Metabolism and Diabetes, Health Sciences University, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, TUR.

Department of Endocrinology, Metabolism and Diabetes, Health Sciences University, Bursa State Hospital, Bursa, TUR.

出版信息

Cureus. 2024 Oct 17;16(10):e71747. doi: 10.7759/cureus.71747. eCollection 2024 Oct.

Abstract

Background Previous studies have yielded conflicting findings on the routine use of serial prolactin (PRL) measurement in patients with inconsistent signs or symptoms of mild hyperprolactinemia (HP). Therefore, we aimed to evaluate the effectiveness of serial PRL measurement and a previously undefined parameter which is the PRL decrease rate (PDR) method in the diagnosis of mild HP and prolactinoma. Materials and methods The data obtained from medical charts of patients in the sample population included serial PRL values at 0 minute (min), 30 min, and 60 min as well as macroprolactinemia (mPRL) levels. PDR was defined as the ratio of the difference between the PRL levels at 0 min and 60 min to the PRL level at 0 min. Results  We obtained referral PRL (rPRL) levels from the files of 221 of 268 patients referred for HP. Of those referred, 153 (69.2%) had mild HP. Of the 165 patients in the serial PRL measurement group, HP was detected in 76 (46.1%), and stress-induced PRL elevation was found in 24 (14.5%). Of the 101 patients in the single PRL measurement group, HP was detected in 72 (69.9%; p<0.001). Moreover, a PDR score of 38.1% had 99% specificity and 26% sensitivity in HP exclusion, and a PDR score of 20.6% had 100% specificity and 30% sensitivity in prolactinoma exclusion. Conclusion In cases where clinical findings are insufficient, the serial PRL measurement method combined with the PDR for the diagnosis of prolactinoma and HP appears to be more reliable than the single measurement method.

摘要

背景 先前的研究对于轻度高泌乳素血症(HP)体征或症状不典型患者常规进行系列泌乳素(PRL)测定的结果存在矛盾。因此,我们旨在评估系列PRL测定以及一个此前未定义的参数即PRL下降率(PDR)方法在诊断轻度HP和泌乳素瘤中的有效性。

材料与方法 从样本人群患者的病历中获取的数据包括0分钟(min)、30分钟和60分钟时的系列PRL值以及大分子泌乳素血症(mPRL)水平。PDR定义为0分钟和60分钟时PRL水平差值与0分钟时PRL水平的比值。

结果 我们从268例因HP转诊患者中的221例档案中获取了转诊PRL(rPRL)水平。在这些转诊患者中,153例(69.2%)患有轻度HP。在系列PRL测定组的165例患者中,76例(46.1%)检测到HP,24例(14.5%)发现有应激性PRL升高。在单次PRL测定组的101例患者中,72例(69.9%;p<0.001)检测到HP。此外,PDR评分38.1%在排除HP时具有99%的特异性和26%的敏感性,PDR评分20.6%在排除泌乳素瘤时具有100%的特异性和30%的敏感性。

结论 在临床发现不足的情况下,系列PRL测定方法结合PDR用于诊断泌乳素瘤和HP似乎比单次测定方法更可靠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1594/11569383/f2f021f832b5/cureus-0016-00000071747-i01.jpg

相似文献

4
Control of prolactin secretion.催乳素分泌的调控
Klin Wochenschr. 1990 Dec 4;68(23):1157-67. doi: 10.1007/BF01815271.

本文引用的文献

6
Serial prolactin sampling as a confirmatory test for true hyperprolactinemia.行催乳素序贯采样作为真性高催乳素血症的确诊试验。
Endocrinol Diabetes Nutr (Engl Ed). 2020 Oct;67(8):525-529. doi: 10.1016/j.endinu.2019.11.006. Epub 2020 Feb 26.
9
Should macroprolactin be measured in all hyperprolactinaemic sera?是否应对所有高催乳素血症血清进行巨催乳素检测?
Clin Endocrinol (Oxf). 2009 Oct;71(4):466-9. doi: 10.1111/j.1365-2265.2009.03577.x. Epub 2009 Mar 6.
10
Hyperprolactinemia and prolactinomas.高催乳素血症与催乳素瘤
Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii. doi: 10.1016/j.ecl.2007.10.013.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验